Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

atherosclerotic cardiovascular disease

Why the 2017 ESC/EAS practical guidance on PCSK9 inhibition is needed

Why the 2017 ESC/EAS practical guidance on PCSK9 inhibition is needed

In the largest US analysis to date, higher LDL cholesterol levels were not associated with higher payer approval rates for PCSK9 inhibitor therapy. These data reaffirm the need for practical guidance, such as that published by a Joint Task Force from the European Society of…

read more »